Physician profile
Anthony Joseph Smith
NPI 1508959495
$1,374.09
in general payments reported to CMS, 2019-2025
25 companies · $82.36 in 2025
The $82.36 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $396 · 2020: $12.35 · 2021: $11.62 · 2022: $162 · 2023: $483 · 2024: $228 · 2025: $82.36.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $708 · Education: $84.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $708.08 |
| Education | $84.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $180.63 | 2022-2024 | |
| Abbvie INC. | $142.82 | 2019 | |
| Hologic Sales and Service, LLC | $134.00 | 2019-2023 | Fluent Fluid Management System, Aptima |
| Astellas Pharma US INC | $131.24 | 2023-2024 | Myrbetriq, Veozah |
| Avanos Medical | $125.94 | 2019 | |
| Exeltis, USA INC. | $96.49 | 2022-2024 | Slynd |
| Sage Therapeutics, LLC | $74.81 | 2024-2025 | Zurzuvae |
| Sumitomo Pharma America, INC. | $68.14 | 2023 | Myfembree |
| Bayer Healthcare Pharmaceuticals INC. | $48.60 | 2022-2023 | |
| Channel Medsystems, INC. | $43.31 | 2022 | |
| Avion Pharmaceuticals | $41.88 | 2020-2023 | Balcoltra |
| Mayne Pharma Commercial LLC | $39.61 | 2023-2025 | |
| Exact Sciences Corporation | $29.41 | 2024 | Cologuard Collection Kit |
| Organon LLC | $27.55 | 2022-2024 | |
| Mdd US Operations, LLC | $25.87 | 2019 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gynesonics, INC. | $21.32 | 2023 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Myovant Sciences INC. | $21.15 | 2022 | |
| Becton, Dickinson and Company | $21.02 | 2025 | Bd Max System, Bd Max Instrument |
| Almatica Pharma LLC | $20.16 | 2025 | Loreev Xr |
| Meditrina | $17.06 | 2024 | |
| Kci USA, INC. | $14.88 | 2023 | Prevena |
| Millicent US INC | $13.66 | 2025 | Intrarosa |
| Minerva Surgical, INC | $12.87 | 2023 | |
| Supernus Pharmaceuticals, INC. | $11.62 | 2021 | |
| Aspira Women'S Health INC | $10.05 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.